Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of the interaction between MDM2 and P53

Inhibitors of the interaction between MDM2 and P53

US Patent 8232298 · Granted Jul 31, 2012

Estimated economic value: $66,960,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of the interaction between MDM2 and P532023
(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxalin2022
Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors2021
RSV antiviral pyrazolo- and triazolo-pyrimidine compounds2021
Cosmetic compositions and method of treating the skin2021
Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors2021
RSV antiviral pyrazolo- and triazolo-pyrimidine compounds2020
Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors2020
RSV antiviral pyrazolo- and triazolo-pyrimidine compounds2019
Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors2019
Substituted pyridine-piperazinyl analogues as RSV antiviral compounds2018
Imidazopyridazine derivatives as PI3KB inhibitors2018